Yingqi Zhao, PhD

/content/dam/www/faculty-photos/Z/yingqi-zhao/Yingqi-Zhao.jpg
Dr. Yingqi Zhao PhD
faculty member

Yingqi Zhao, PhD

Professor, Biostatistics Program, Public Health Sciences Division, Fred Hutch

Professor, Biostatistics Program
Public Health Sciences Division, Fred Hutch

Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch

Member
Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch

Fax: 206.667.4408

With the goal of improving patient outcomes, Dr. Yingqi Zhao’s work focuses on developing novel statistical and machine learning methods for personalized medicine, dynamic treatment regimes, disease screening and surveillance, clinical trial design, and electronic health records. Specific applications of her work include improving cancer immunotherapy trial design and analysis, early detection of cancer, health care delivery for complex Type 2 diabetes patients, and childhood obesity surveillance. Dr. Zhao collaborates with the Fred Hutch–based Statistics and Data Management Center for the SWOG Cancer Research Network and Early Detection Research Network.

Education

PhD, Biostatistics, University of North Carolina Chapel Hill, 2012

BS, Statistics, Wuhan University, 2006

Research Interests

Statistical methods for personalized medicine, dynamic treatment regimes and survival analysis using data from both clinical trials and complex observational studies.

Statistical Areas of Interest:

Statistical methods for precision treatment and precision prevention

Design of clinical trials for both therapeutic and early detection purposes

Methods for analyzing data from real-world studies, such as electronic medical records, administrative data

Public health surveillance

Application Areas:

Early detection of cancer

Cancer therapeutics

Cancer survivorship

Diabetes

Awards & Honors

2020 - UNC Biostatistics Grizzle Alumni Award, Biostatistics, UNC-CH

2011 - Best Paper in Biometrics, International Biometrics Society

Current Projects

Improve the Design and Analysis of Randomized Screening Trial in a New Era of Cancer Early Detection

Statistical Methods for Design and Analysis of Cancer Immunotherapy Trials

Developing methods for advancing the early detection of pancreatic ductal adenocarcinoma leveraging electronic medical records data

Find a Clinical Trial

Dr. Zhao in the News